ICAM1 and rheumatoid arthritis: Moreover, it is capable of increasing the surface expression of co-stimulatory molecules, such as CD54, CD40, and CD80, and it also enhances B-cell proliferation and inhibits neutrophil apoptosis in rheumatoid arthritis [47].